Trial
NCT04984798
Vitamin E Efficacy in HI/HA
Phase IIWITHDRAWNREGULATORYConfidence: HIGH
Sponsor
Children's Hospital of Philadelphia
Collaborators
University of Pennsylvania; Lawson Wilkins Pediatric Endocrine Society
Condition
Hyperinsulinism-Hyperammonemia Syndrome
Intervention
Vitamin E
Why stopped
No study activity took place. The IND was withdrawn with the FDA by the Sponsor Investigator because of insurmountable hurdles in moving proposed research forward
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-12-13